Published on 29 April 2020
Clinical trials for trastuzumab biosimilars
Author(s): GaBI Journal Editor
biosimilar, clinical trials, trastuzumab
DOI: 10.5639/gabij.2020.0902.014
5.023 views
Published on 29 April 2020
Author(s): GaBI Journal Editor
biosimilar, clinical trials, trastuzumab
DOI: 10.5639/gabij.2020.0902.014
5.023 views
Published on 25 March 2020
Author(s): Jian Wang, MD, PhD, Professor Andrea Laslop, MD, Professor John-Joseph Borg, Robin Thorpe, PhD, FRCPath, Yolanda Elias Gramajo, MD
biologicals, biosimilars, Colombia, INVIMA
DOI: 10.5639/gabij.2020.0903.022
8.649 views
Published on 25 March 2020
Author(s): Jalal Naeli, MD
biopharmaceuticals, Iran, reference medicinal product
2.568 views
Published on 25 March 2020
biologicals, biopharmaceuticals, biosimilars, Latin America
DOI: 10.5639/gabij.2020.0902.011
13.577 views
Published on 24 March 2020
2.099 views
Published on 24 March 2020
2.367 views
Published on 24 March 2020
Author(s): Professor Philip D Walson, MD
DOI: 10.5639/gabij.2020.0901.001
2.457 views
Published on 18 March 2020
Author(s): Professor Alain Astier, PharmD, PhD
analysis, biosimilar, protein, spectroscopy, structure
DOI: 10.5639/gabij.2020.0902.009
9.012 views
Published on 18 March 2020
Author(s): GaBI Journal Editor
DOI: 10.5639/gabij.2020.0901.007
10.757 views
Published on 27 February 2020
Author(s): Kevin Klein, PhD
DOI: 10.5639/gabij.2020.0902.012
3.327 views
Published on 19 February 2020
Author(s): Alian A Alrasheedy, BPharm(Hons), MPharm(Clin), PhD, MACP, RPh
health expenditures, medicine prices, pharmaceutical expenditure, pharmaceutical policy, pricing, Saudi Arabia
DOI: 10.5639/gabij.2020.0901.003
23.614 views
Published on 27 November 2019
2.488 views